Pharma innovators commit to use IP differently in poorer nations
Pharma innovators commit to use IP differently in poorer nations In an effort to communicate their IP strategies to the public, 26 pharma innovators have pledged to follow 10 key principles for using IP April 29 2021 In a move that includes the pharma industry’s largest-ever commitment to approach intellectual property differently in poorer countries, 26 companies this week pledged to follow 10 principles that commit them to using IP in ways that deliver value to patients and societies. The pledge, called IP Principles for Advancing Cures and Therapies (IP PACT), was...
Source: managingip.com